Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

Clinical trial NCT07270978 · RECRUITING

Trial details

NCT number: NCT07270978
Sponsor: University of Virginia
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm

Start date: 2026-03-26
Primary completion: 2028-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.